ObvioHealth, a Orlando, Florida-based virtual health research organization, raised $17m in funding.
The round was led by TKS1.
The company intends to use the funds to continue to expand operations and its business reach.
Led by Ivan Jarry, ObvioHealth provides a proprietary platform designed for digital and remote/at-home research. Its proprietary application allows subjects to participate in studies and trials from homes. With device integration that enables real-time data collection and virtual chats that increase protocol compliance, the platform offers a better experience to research subjects and sponsors.
Earlier this month, the company announced it is sponsoring a virtual research study in the fight against COVID-19. The study will monitor the prevalence, symptoms and immune response of 10,000 participants in the United States over the next 12 months.